Head-to-head · WeighScore
BiltRx vs Roen Rx
By GLP-1 ScorecardUpdated
Score comparison
BiltRx has the higher recorded score — 75.3/100 to 55.4/100.
BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.
Before you choose
Before comparing the headline prices, the BiltRx review and the Roen Rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, BiltRx vs RxSpan MD and CoreAge Rx vs Roen Rx compare each of them with another graded program, and the list of alternatives to BiltRx ranks the programs closest to BiltRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Lttl review covers one graded close to these two, at 63.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | BiltRx | Roen Rx |
|---|---|---|
| WeighScore | 75.3/100 | 55.4/100 |
| Grade | C | C |
| Site position | #59 | #470 |
| Semaglutide | $82/mo advertised medication starting price; confirm care and shipping charges | $151/mo (3-month plan, plus a separate fee, compounded) |
| Tirzepatide | $130/mo advertised medication starting price; confirm care and shipping charges | $216/mo (3-month offer, plus a separate fee, compounded) |
| Coverage | All 50 states advertised | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes 12-week package totals
- Explains the consultation charge if treatment is declined
What to consider
- Confirm whether consultation and shipping are included in the selected plan
- Renewal cancellation does not refund an approved order
Site position #470 · C
FDAWarning letter issued to Roen Health, Inc. dba RoenRx in June 2026. See the FDA warning-letter database.
Strengths
- Insurance coordination for eligible branded prescriptions
- General membership and separate medication-included bundles
- Dedicated wellness coaching and secure messaging
- Quarterly compounded medication offers, with separate care fees to confirm
What to consider
- Confirm treatment-specific state eligibility and assigned clinician/pharmacy
- Insurance coverage and a $25 copay are not guaranteed
- General membership excludes medication; separate bundles include it with possible higher-dose extras
- Weight-loss coaches are not licensed dietitians or nutritionists
- Full ineligibility-refund advertising differs from general nonrefundable fees; confirm the selected exception
- FDA issued Roen Health, Inc. dba RoenRx a warning letter in June 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.